These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Validity and reliability of the Turkish Örebro musculoskeletal pain screening questionnaire-short form.
    Author: Özdinç S, Pekçetin S, Can H, Ata H, Süslü B, Birtane M.
    Journal: Work; 2022; 72(1):333-341. PubMed ID: 35466918.
    Abstract:
    BACKGROUND: The Örebro Musculoskeletal Pain Screening Questionnaire (ÖMPSQ) is one of the most recognized and widely used instruments for identifying the risk of pain chronicity. OBJECTIVE: The aim of the study was to provide the reliability and validity of the Turkish ÖMPSQ-Short Form (ÖMPSQ-SF). METHODS: Fifty-seven acute and subacute low back pain patients were included in the study. ÖMPSQ short form and long form, Oswestry Disability Index (ODI), Central Sensitization Inventory (CSI), fear-avoidance beliefs questionnaires were applied simultaneously for validation. The ÖMPSQ-SF was re-applied after 7-10 days to determine test-retest reliability. The data were analyzed by the paired-samples t test, correlation analysis, Cronbach's alpha, intraclass correlation coefficient (ICC) and confirmatory factor analysis. RESULTS: The mean age of the participants was 39.05±15.68 years. Cronbach's alpha was 0.723, and the ICC was 0.84. There were moderate to strong correlation among the ÖMPSQ-SF and the ODI, CSI, ÖMPSQ-long form, Fear-Avoidance Beliefs Questionnaire work subscale (r = 0.72, r = 0.353, r = 0.648, r = 0.457 respectively). CONCLUSION: The results show that the Turkish version of the ÖMPSQ-SF is a valid and reliable questionnaire and could be used in clinical and scientific studies.
    [Abstract] [Full Text] [Related] [New Search]